[Form 4] MOODYS CORP /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Moody’s Corporation (MCO)10/15/2025 pursuant to a Rule 10b5-1 plan adopted on July 30, 2024.

He exercised employee stock options and acquired common shares: 55 at $80.81, 135 at $94.18, and 91 at $113.34. He then sold 415 common shares at an average price of $481.09. Following these transactions, he beneficially owned 61,081.984 shares directly.

In the derivative table, the option series at $80.81 and $94.18 show 0 remaining after exercises, while the $113.34 option series shows 6,517 derivative securities beneficially owned, with an expiration date of 02/23/2027.

10/16/2025 - 04:21 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fauber Robert

(Last) (First) (Middle)

7 WORLD TRADE CENTER

250 GREENWICH STREET

(Street)

NEW YORK NY 10007

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOODYS CORP /DE/ [ MCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		M		55(1)	A	$80.81	61,270.984	D
Common Stock	10/15/2025		M		135(1)	A	$94.18	61,405.984	D
Common Stock	10/15/2025		M		91(1)	A	$113.34	61,496.984	D
Common Stock	10/15/2025		S		415(1)	D	$481.09	61,081.984	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$80.81	10/15/2025		M			55	02/12/2017(2)	02/12/2026	Common Stock	55	$0	0	D
Employee Stock Option (right to buy)	$94.18	10/15/2025		M			135	07/01/2017(2)	07/01/2026	Common Stock	135	$0	0	D
Employee Stock Option (right to buy)	$113.34	10/15/2025		M			91	02/23/2018(2)	02/23/2027	Common Stock	91	$0	6,517	D

Explanation of Responses:

1. Exercise and sale of shares pursuant to a Rule 10b5-1 plan adopted by Mr. Fauber on July 30, 2024.

2. One fourth of the options vest each year beginning with the date indicated.

Remarks:

	Elizabeth McCarroll, by power of attorney for Robert Fauber	10/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MCO's CEO report on the Form 4 dated 10/15/2025?

He reported option exercises and a sale of common stock under a Rule 10b5-1 plan.

How many MCO shares did the CEO sell and at what price?

He sold 415 shares at an average price of $481.09.

Which options did the CEO exercise on 10/15/2025?

He exercised 55 options at $80.81, 135 at $94.18, and 91 at $113.34.

How many MCO shares does the CEO own after these transactions?

He beneficially owns 61,081.984 common shares directly.

Were the trades made under a 10b5-1 plan for MCO?

Yes. The filing notes a Rule 10b5-1 plan adopted on July 30, 2024.

What derivative securities remain after the reported transactions?

The filing shows 6,517 stock options at an exercise price of $113.34, expiring 02/23/2027.